Flu

[biglentil]

Watch the video coughs travel 25ft.

https://edhub.ama-assn.org/jn-learning/video-player/18357411 https://edhub.ama-assn.org/jn-learning/video-player/18357411

[Oliver88]

Saskatchewan is doing reasonable, Saskatoon region is the worst area.
1 person currently in ICU

[furrowtickler]

Thought this was spot on ....

[burnt]

Some hopeful words from a credible source.

"This is the Beginning of the End of the Pandemic" - Dr. Stephen Smith Announces Hydroxy-Choloroquine Study that is "Game Changer" in Battle Against Coronavirus

https://www.thegatewaypundit.com/2020/04/this-is-the-beginning-of-the-end-of-the-pandemic-dr-stephen-smith-announces-hydroxy-choloroquine-study-that-is-game-changer-in-battle-against-coronavirus-video/ https://www.thegatewaypundit.com/2020/04/this-is-the-beginning-of-the-end-of-the-pandemic-dr-stephen-smith-announces-hydroxy-choloroquine-study-that-is-game-changer-in-battle-against-coronavirus-video/

[malleefarmer]

Guess you guys have same tests going on, but a lab in Sydney has found ivermectin is killing cv19 in 48 hours, not sure about method used but far out a sheep and cattle parasite control may be part of solution who would have thought.

Dunno how long the testing etc will take might be to risky who knows. And not fake news.

[wd9]

Guess you guys have same tests going on, but a lab in Sydney has found ivermectin is killing cv19 in 48 hours, not sure about method used but far out a sheep and cattle parasite control may be part of solution who would have thought.

Dunno how long the testing etc will take might be to risky who knows. And not fake news.

In vitro or in vivo?

[malleefarmer]

An anti-parasitic drug available throughout the world has been found to kill COVID-19 within 48 hours. A Monash University-led study has shown a single dose of the drug Ivermectin could stop the SARS-CoV-2 virus growing in cell culture. #coronavirus

Did a bit more research cultured cells and application just pasted on I believe

And even a bit more research think a few countries are fiddling with it presume Canada as well, I’m sure they all talk shop the immunologists

[Guest]

Guess you guys have same tests going on, but a lab in Sydney has found ivermectin is killing cv19 in 48 hours, not sure about method used but far out a sheep and cattle parasite control may be part of solution who would have thought.

Dunno how long the testing etc will take might be to risky who knows. And not fake news.

Usta use it in pigs all the time
One shot and worms out next day

[LEP]

Usta use it in pigs all the time
One shot and worms out next day

Could drop a shot at Rideau cottage. Got a worm there I would like to get rid of.

[malleefarmer]

Usta use it in pigs all the time
One shot and worms out next day

Yeah it’s good for worms but a virus will keep open mind.

[TOM4CWB]

malleefarmer; An anti-parasitic drug available throughout the world has been found to kill COVID-19 within 48 hours. A Monash University-led study has shown a single dose of the drug Ivermectin could stop the SARS-CoV-2 virus growing in cell culture. #coronavirus



Mallee apparently Ivermectin is used on humans all the time:

"Ivermectin Dosage
Medically reviewed by Drugs.com. Last updated on Jan 3, 2020.

OverviewSide EffectsDosageProfessionalInteractionsMore
Applies to the following strengths: 3 mg; 6 mg

Usual Adult Dose for:
Onchocerciasis
Strongyloidiasis
Ascariasis
Cutaneous Larva Migrans
Filariasis
Scabies
Usual Pediatric Dose for:
Filariasis
Additional dosage information:

Renal Dose Adjustments
Liver Dose Adjustments
Dose Adjustments
Precautions
Dialysis
Other Comments
Usual Adult Dose for Onchocerciasis
0.15 mg/kg orally once every 12 months
Patients with heavy ocular infection may require retreatment every 6 months. Retreatment may be considered at intervals as short as 3 months.

Dosage guidelines based on body weight:
15 to 25 kg: 3 mg orally one time
26 to 44 kg: 6 mg orally one time
45 to 64 kg: 9 mg orally one time
65 to 84 kg: 12 mg orally one time
85 kg or more: 0.15 mg/kg orally one time

Usual Adult Dose for Strongyloidiasis
0.2 mg/kg orally once
In immunocompromised (including HIV) patients, the treatment of strongyloidiasis may be refractory requiring repeated treatment (i.e., every 2 weeks) and suppressive therapy (i.e., once a month), although well-controlled studies are not available. Cure may not be achievable in these patients.

Dosage guidelines based on body weight:
15 to 24 kg: 3 mg orally one time
25 to 35 kg: 6 mg orally one time
36 to 50 kg: 9 mg orally one time
51 to 65 kg: 12 mg orally one time
66 to 79 kg: 15 mg orally one time
80 kg or more: 0.2 mg/kg orally one time

Usual Adult Dose for Ascariasis
0.2 mg/kg orally once...

https://www.drugs.com/dosage/ivermectin.html

Drug Companies would never go for this... just like cheap malaria drugs...

Bulletin of the World Health Organization
Bulletin
Past issues
Information for contributors
Editorial members
How to order
About the Bulletin
Disclaimer
Mass treatment with ivermectin: an underutilized public health strategy

Rick Speare (1) & David Durrheim (1)
Ivermectin was a revolutionary drug in the 1980s, the forerunner of a new group of antiparasitic agents with activity against both parasitic nematodes and arthropods. Initially it was marketed for veterinary use by Merck & Co. Inc.; it was used largely for nematode control in cattle, horses, pigs and dogs and became the standard for control of the ectoparasitic disease, scabies. The injectable cattle formulation, Ivomec, became the world’s most profitable veterinary drug (1).

Merck recognized Ivermectin’s potential for human use, particularly in the control of filariasis and most notably onchocerciasis, the cause of river blindness in West Africa, in the early 1980s. In collaboration with WHO, nongovernmental organizations and affected national governments, the company initiated a drug donation programme for onchocerciasis control that subsequently became the global model for philanthropic partnerships between pharmaceutical companies and countries unable to afford the drug. Profits from the veterinary use of ivermectin supported this programme (1).

Merck’s patent on ivermectin expired in 1996, though it was extended for different periods in various countries. Thus, other companies’ ivermectin preparations are now commercially available. Bioavailability of drugs depends on formulation and manufacturing processes, so the results obtained with the ivermectin manufactured by Merck may not apply to the new products. It is thus encouraging to see clinical trials evaluating new formulations of this valuable drug.

Heukelbach et al. (pp.563–579) report a study that investigates changes in parasitological parameters and the occurrence of side-effects after treatment with ivermectin in a Brazilian community heavily parasitized with intestinal helminths and ectoparasites. The trial was unblinded and uncontrolled, but provided valuable information. Community members, ineligible for ivermectin, were treated with mebendazole, albendazole or deltamethrin to achieve a high level of coverage. Of particular importance was the finding that ivermectin was highly effective against Strongyloides stercoralis, with a 94% reduction in prevalence that was sustained for nine months. This provided field evidence for a paper that predicted that strongyloidiasis in heavily endemic communities could be successfully controlled with a highly effective drug, owing to its low transmission potential (2). The evidence presented by Heukelbach et al. adds considerably to evidence from smaller-scale controlled trials (3–6).

Ivermectin has valuable public health applications for controlling strongyloidiasis and scabies (by breaking the infection cycle through its the****utic effect) and filariasis, through its effect on transmission. Ivermectin also acts against other intestinal nematodes, but it is not the most effective drug available. In control programmes for filariasis, ivermectin is the drug of choice in areas with onchocerciasis, but can be replaced by diethylcarbamazine for control of other filarial diseases.

Since ivermectin’s use in the human field, adverse reactions occurred in 50% or more of the population (7) and ivermectin was “tainted” with a high adverse reaction profile, despite evidence that the majority of such reactions were attributable to the interaction between the drug and the disease, not to the drug itself (8). A number of follow-up studies have found that inadvertent filariasis mass campaign use of ivermectin during pregnancy has not been associated with adverse pregnancy outcomes or negative effects on pregnant women or their offspring (9). The lack of serious adverse events found in the study reported by Heukelbach et al. is reassuring, as the low incidence of minor adverse events fell from 14% after the initial treatment to 5% 10 days later.

[newguy]

I assume you are referring to the injectable and not the pour on.When our cats get ear mites 2 drops in each ear and they are gone.